STT
60
7
HP
36
3
CNP
44
8
LEG
28
6
VLO
33
4
AZO
48
3
EMN
48
-2
LYB
37
12
ZTS
27
-9
SEE
45
-4
MRK
25
2
BXP
47
3
VMC
57
-5
HES
62
4
MCD
52
-2
PBI
60
17
C
50
-4
MMM
28
-2
TAP
51
6
PSX
34
4
STT
60
7
HP
36
3
CNP
44
8
LEG
28
6
VLO
33
4
AZO
48
3
EMN
48
-2
LYB
37
12
ZTS
27
-9
SEE
45
-4
MRK
25
2
BXP
47
3
VMC
57
-5
HES
62
4
MCD
52
-2
PBI
60
17
C
50
-4
MMM
28
-2
TAP
51
6
PSX
34
4
Financhill
Back

InflaRx NV 10K Form

Sell
41

IFRX
InflaRx NV

Last Price:
1.55
Seasonality Move:
8.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IFRX News And Ratings

See the #1 stock for the next 7 days that we like better than IFRX

IFRX Financial Statistics

Sales & Book Value

Annual Sales: $68.3K
Cash Flow: $-12.94M
Price / Cash Flow: 0
Annual Sales: $1.50
Price / Book: 1.04

Profitability

EPS (TTM): -0.88610
Net Income (TTM): $-50.67M
Gross Margin: $-507.93K
Return on Equity: -44.91%
Return on Assets: -41.76%

InflaRx NV Earnings Forecast

Key InflaRx NV Financial Ratios

  • The Gross Profit Margin over the past 3 years for IFRX is -743.67%.
  • The Selling, General & Administrative Expenses for IFRX have been equal to 25,554.89% of Gross Profit Margin.
  • The Research & Development expenses have been 65,026.50% of Revenue.
  • The Interest Expense is -0.08% of Operating Income.
  • The Net Earning history of IFRX is -67,631.41% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

InflaRx NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IFRX
CUSIP: N44821
Website: inflarx.de

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.91
Quick Ratio: 7.5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IFRX Technical Analysis vs Fundamental Analysis

Sell
41
InflaRx NV (IFRX) is a Sell

Is InflaRx NV a Buy or a Sell?

  • InflaRx NV stock is rated a Sell
    The current InflaRx NV [IFRX] share price is $1.56. The Score for IFRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.